Dou Changlin
President at Boan Boston LLC
Net worth: 9 M $ as of 29/04/2024
Profile
Dou Changlin is currently the COO, Director, and President-Research & Development at Boan Boston LLC.
Prior to this, he worked as the Director of Biotechnology at Luye Pharma Group Ltd.
from 2012 to 2013 and as the Chief Technical Officer at A-Bio Pharma Pte Ltd.
from 2011 to 2012.
Mr. Changlin received his undergraduate degree from Peking University in 1984, his doctorate from Stony Brook University in 1995, and his graduate degree from the Chinese Academy of Sciences in 1998.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
29/06/2023 | 6,800,000 ( 1.34% ) | 9 M $ | 29/04/2024 |
Dou Changlin active positions
Companies | Position | Start |
---|---|---|
Boan Boston LLC | President | - |
Former positions of Dou Changlin
Companies | Position | End |
---|---|---|
LUYE PHARMA GROUP LTD. | Corporate Officer/Principal | 30/11/2013 |
A-Bio Pharma Pte Ltd.
A-Bio Pharma Pte Ltd. Miscellaneous Commercial ServicesCommercial Services A-Bio Pharma Pte Ltd. provides pharmaceutical research services. It offers manufacturing solutions for mammalian cell culture systems, including process development, optimization, manufacturing scale-up, GMP production, quality control and regulatory compliance. The company was founded in 2001 and is headquartered in Singapore. | Chief Tech/Sci/R&D Officer | 31/05/2012 |
Training of Dou Changlin
Peking University | Undergraduate Degree |
Stony Brook University | Doctorate Degree |
Chinese Academy of Sciences | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
LUYE PHARMA GROUP LTD. | Health Technology |
Private companies | 2 |
---|---|
A-Bio Pharma Pte Ltd.
A-Bio Pharma Pte Ltd. Miscellaneous Commercial ServicesCommercial Services A-Bio Pharma Pte Ltd. provides pharmaceutical research services. It offers manufacturing solutions for mammalian cell culture systems, including process development, optimization, manufacturing scale-up, GMP production, quality control and regulatory compliance. The company was founded in 2001 and is headquartered in Singapore. | Commercial Services |
Boan Boston LLC |
- Stock Market
- Insiders
- Dou Changlin